Girish Mahajan (Editor)

Interferon alfa 2b

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
MedlinePlus
  
a690006

IUPHAR/BPS
  
8338

ATC code
  
L03AB05 (WHO)

Pregnancy category
  
US: C (Risk not ruled out)

Routes of administration
  
Subcutaneous, intramuscular

Legal status
  
UK: POM (Prescription only) US: ℞-only

Interferon alfa 2b is an antiviral drug originally discovered in the laboratory of Charles Weissmann at the University of Zurich, developed at Biogen, and ultimately marketed by Schering-Plough under the tradename Intron-A. It has been used for a wide range of indications, including viral infections and cancers.

This drug is approved around the world for the treatment of chronic hepatitis C, chronic hepatitis B, hairy cell leukemia, chronic myelogenous leukemia, multiple myeloma, follicular lymphoma, carcinoid tumor, and malignant melanoma.

References

Interferon alfa-2b Wikipedia